Welcome, MedTech Professionals.
W19 Edition of The MedTech AI Monitor
Hey there,
Welcome to Week 19 edition of The MedTech AI Monitor. This week, we’re checking out major FDA clearances, real-world AI deployment in hospitals, and moves from healthcare execs betting on AI to reshape operations and outcomes.
If you’re looking to stay sharp on the latest AI trends in medical imaging, diagnostics, and revenue cycle insights- this one's for you.
Let’s get into it.
Greg Matson
tl;dr
Data + AI summit in June, free virtual tickets
BrightHeart’s AI detects fetal heart defects in real time
85% of execs say AI boosts RCM efficiency
1. GE HealthCare Rolls Out AI-Equipped SPECT/CT Nuclear Medicine Scanner
GE HealthCare has received FDA clearance for its new AI-powered SPECT/CT scanner, the Aurora, which integrates dual-head gamma ray SPECT with X-ray CT to enhance imaging capabilities across cardiology, oncology, and neurology. Equipped with Clarify DL deep learning software, the system improves image quality by reducing noise and increasing clarity. With a larger bore and broader detector coverage than other hybrid systems, it supports a wide array of radiopharmaceuticals and theranostics. The first U.S. installation will be at University Hospitals in Cleveland, following a long-term partnership with GE HealthCare. The scanner also holds CE Mark approval for use in Europe. [Link]
2. BrightHeart Gains Clearance for Heart Defect Detection Platform
BrightHeart has secured a FDA 510(k) clearance for its AI-driven prenatal congenital heart defect (CHD) detection platform, now allowing real-time analysis via a cart-side tablet. This enhancement enables clinicians to identify structural markers during fetal ultrasound exams, improving CHD detection rates by over 15%. The platform aims to make expert-level ultrasound diagnostics accessible across diverse clinical settings, regardless of resource levels. Following a successful pilot and rapid clearance through the FDA’s special 510(k) process, BrightHeart is preparing for a limited market release in U.S. clinics. The innovation addresses a critical global need, as CHDs affect 1% of births, with most untreated in low- and middle-income countries. [Link]
3. Vast Majority of Top Healthcare Execs Betting on AI For Rev Cycle Efficiencies
A new Everest Group survey, supported by Omega Healthcare, reveals that 85% of senior healthcare executives believe AI will significantly enhance revenue cycle management (RCM) efficiency within five years. These leaders view AI—including generative and agentic AI—not just as cost-saving tools but as strategic enablers of financial performance and patient-centric care. The survey highlights a shift from basic RCM outsourcing to AI-powered, outcome-based partnerships, with 66% of respondents naming AI/ML as their top investment priority by 2030. Despite adoption challenges like skill gaps and legacy system integration, healthcare providers are finding early success using AI for eligibility verification, claims analysis, and clinical documentation. The study forecasts a digital-first, AI-driven RCM landscape where advanced automation will become foundational to healthcare operations. [Link]
📌 AI Job Board
AI Content Strategist, Medical Leverage, $75,000 - $150,000/yr
Director, AI Medical Device Programs, Prenuvo
VP, Privacy and Compliance Officer, Personify Health, $200,000 - $235,000/yr
Director, Global Supply Chain Process Excellence (Hybrid), Insulet Corporation, $161,550 - $242,325/yr
🗞️ In Other News
🎟️ Upcoming Events
Data Innovation Summit (Online)
- Date: Today 07 May and Tomorrow 08-May
- Location: Online and Onsite: Stockholm
- Cost: €249 online, €599 in person.
Data + AI Summit
- Date: June 9-12, 2025.
- Location: Hybrid - San Francisco, California, US, and available online.
- Cost: $1,395-$1,895 in-person. Free for virtual admission.
The views and opinions expressed in this email are for informational purposes only. They do not constitute legal advice. Readers are encouraged to consult with their own legal counsel regarding any specific legal questions or issues related to the topics discussed.
